SSgA Funds Management, Inc. recently announced the acquisition of new stake in Coterra Energy Inc (NYSE:CTRA). The institutional investor has increased its shareholding in the Energy company by 1.06% to 50.76 million shares with purchase of 0.53 million shares. This fresh investment now brings its stake to 6.75% valued currently at $1.3 billion. In addition, BlackRock Fund Advisors raised its holdings by 36690.0 to 44.35 million shares. And Geode Capital Management LLC has lifted its position by 0.92% or 0.17 million shares – to 18.73 million shares.
Currently, there are 768.24M common shares owned by the public and among those 738.85M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 28 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, accounting for 800,980 shares. Insider sales of the common stock occurred on 7 occasions, with total insider shares sold totaling 789,186 shares.
The top 3 mutual fund holders in Coterra Energy Inc are Vanguard Total Stock Market ETF, Vanguard 500 Index Fund, and SPDR Series – Energy Select Secto. Vanguard Total Stock Market ETF owns 22.49 million shares of the company’s stock, all valued at over $574.0 million. The company bought an additional 19258.0 shares recently to bring their total holdings to about 2.99% of the shares outstanding. Vanguard 500 Index Fund sold -0.1 million shares to see its total holdings shrink to 18.37 million shares valued at over $468.68 million and representing 2.44% of the shares outstanding. SPDR Series – Energy Select Secto bought 72420.0 shares to bring its total holdings to over 18.26 million shares at a value of $466.1 million. SPDR Series – Energy Select Secto now owns shares totaling to 2.43% of the shares outstanding.
However, the script later moved the day high at 24.51, down -0.12%. The company’s stock has a 5-day price change of -4.77% and -17.74% over the past three months. CTRA shares are trading -4.58% year to date (YTD), with the 12-month market performance down to -2.30% lower. It has a 12-month low price of $22.25 and touched a high of $29.89 over the same period. CTRA has an average intraday trading volume of 6.81 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.15%, -5.56%, and -7.22% respectively.
Institutional ownership of Coterra Energy Inc (NYSE: CTRA) shares accounts for 91.12% of the company’s 768.24M shares outstanding. Mutual fund holders own 38.09%, while other institutional holders and individual stakeholders account for 53.42% and 2.83% respectively.
It has a market capitalization of $18.32B and a beta (3y monthly) value of 0.19. The stock’s trailing 12-month PE ratio is 8.41, while the earnings-per-share (ttm) stands at $2.89. The company has a PEG of 0.21 and a Quick Ratio of 1.01 with the debt-to-equity ratio at 0.20. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.81% over the week and 1.81% over the month.
Analysts forecast that Coterra Energy Inc (CTRA) will achieve an EPS of $CTRU for the current quarter, $19.68 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Corteva, Inc. while analysts give the company a high EPS estimate of $Atara Biotherapeutics, Inc.. Comparatively, EPS for the current quarter was $Kintara Therapeutics, Inc. a year ago. Earnings per share for the fiscal year are expected to decrease by -53.57%, and -1.19% over the next financial year. EPS should shrink at an annualized rate of 40.83% over the next five years, compared to 87.35% over the past 5-year period.
Looking at the support for the CTRA, a number of firms have released research notes about the stock. BofA Securities stated their Buy rating for the stock in a research note on January 05, 2024, with the firm’s price target at $31.
